Skip to main content
. 2020 Mar 10;19(5):3487–3494. doi: 10.3892/ol.2020.11452

Table III.

Multivariate analysis of the independent prognostic characteristics for primary gastrointestinal diffuse large B-cell lymphoma.

Characteristic OS, HR (95% CI) P-value PFS, HR (95% CI) P-value
miR-150 expression (Low vs. high) 2.043 (1.147–3.638) 0.015a 2.074 (1.154–3.730) 0.015a
IPI score (0–2 vs. 3–5) 2.030 (1.262–3.264) 0.004a 2.082 (1.295–3.346) 0.002a
Treatment (CHOP vs. R-CHOP) 1.305 (0.552–3.085) 0.544 1.499 (0.633–3.549) 0.357
a

P<0.05. OS, overall survival; PFS, progression-free survival; HR, hazard ratio; CI, confidence interval; miR, microRNA; IPI, International Prognostic Index; CHOP, cyclophosphamide, doxorubicin, vincristine and prednisoneor; R-CHOP, CHOP-like regimen with rituximab.